Faeth Therapeutics (FTH) Net Equity Issued and Repurchased (2020 - 2026)

Faeth Therapeutics (FTH) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $200.0 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $200.0 million; the trailing twelve-month figure through Jun 2026 stood at $200.0 million (up 19999900.0% YoY), and the FY2021 full-year result was $23.5 million, down 9.95% from the prior year.
• Net Equity Issued and Repurchased rose to $200.0 million in Q1 2026 per FTH's latest filing, from $1000.0 in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $200.0 million in Q1 2026 and bottomed at $200.0 million in Q1 2026.